NovoCure - 9 Year Stock Price History | NVCR
Historical daily share price chart and data for NovoCure since 2015 adjusted for splits and dividends. The latest closing stock price for NovoCure as of April 18, 2024 is 12.05.
- The all-time high NovoCure stock closing price was 225.58 on June 23, 2021.
- The NovoCure 52-week high stock price is 83.60, which is 593.8% above the current share price.
- The NovoCure 52-week low stock price is 10.87, which is 9.8% below the current share price.
- The average NovoCure stock price for the last 52 weeks is 26.97.
| NovoCure Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 14.5345 | 14.4000 | 17.2900 | 12.0500 | 12.0500 | -19.29% |
| 2023 | 45.8561 | 67.9400 | 118.8100 | 11.1300 | 14.9300 | -79.65% |
| 2022 | 75.5782 | 80.1000 | 89.9000 | 56.6000 | 73.3500 | -2.30% |
| 2021 | 150.8145 | 161.3200 | 225.5800 | 75.0800 | 75.0800 | -56.61% |
| 2020 | 90.5883 | 76.8600 | 174.1400 | 57.0500 | 173.0400 | 105.34% |
| 2019 | 65.1258 | 32.7200 | 97.8000 | 31.9600 | 84.2700 | 151.70% |
| 2018 | 31.4882 | 20.3000 | 52.6300 | 19.3000 | 33.4800 | 65.74% |
| 2017 | 14.7903 | 7.8500 | 21.9000 | 6.1000 | 20.2000 | 157.32% |
| 2016 | 10.9802 | 22.5500 | 22.7400 | 5.9500 | 7.8500 | -64.89% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.297B | $0.509B |
| NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $118.437B | 15.37 |
| Cencora (COR) | United States | $47.600B | 19.00 |
| ICON (ICLR) | Ireland | $24.090B | 23.76 |
| DiDi Global (DIDIY) | China | $22.541B | 0.00 |
| Avantor (AVTR) | United States | $16.537B | 22.78 |
| CochLear (CHEOY) | $13.442B | 0.00 | |
| Viatris (VTRS) | United States | $13.316B | 3.80 |
| Revvity (RVTY) | United States | $12.420B | 21.62 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.852B | 21.60 |
| Medpace Holdings (MEDP) | United States | $11.849B | 43.07 |
| Natera (NTRA) | United States | $10.908B | 0.00 |
| Solventum (SOLV) | United States | $10.653B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.029B | 19.34 |
| Doximity (DOCS) | United States | $4.699B | 34.99 |
| Organon (OGN) | United States | $4.568B | 4.42 |
| Progyny (PGNY) | United States | $3.148B | 52.82 |
| Surgery Partners (SGRY) | United States | $3.098B | 28.79 |
| Sotera Health (SHC) | United States | $3.043B | 14.93 |
| Life Times (LTH) | United States | $2.713B | 29.98 |
| GoodRx Holdings (GDRX) | United States | $2.567B | 130.00 |
| Premier (PINC) | United States | $2.473B | 9.05 |
| Teladoc Health (TDOC) | United States | $2.225B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.137B | 6.91 |
| Agilon Health (AGL) | United States | $2.052B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.758B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.432B | 0.00 | |
| Agiliti (AGTI) | United States | $1.365B | 22.29 |
| Alignment Healthcare (ALHC) | United States | $0.935B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.590B | 3.89 |
| Auna S.A (AUNA) | Luxembourg | $0.554B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.528B | 0.00 |
| Enhabit (EHAB) | United States | $0.510B | 46.18 |
| MultiPlan (MPLN) | United States | $0.467B | 0.00 |
| CareDx (CDNA) | United States | $0.429B | 0.00 |
| Beauty Health (SKIN) | United States | $0.409B | 0.00 |
| LifeMD (LFMD) | United States | $0.398B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.378B | 0.00 |
| DocGo (DCGO) | United States | $0.350B | 56.00 |
| Sera Prognostics (SERA) | United States | $0.314B | 0.00 |
| ModivCare (MODV) | United States | $0.295B | 3.91 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.240B | 0.00 |
| Sharecare (SHCR) | United States | $0.237B | 0.00 |
| Biodesix (BDSX) | United States | $0.117B | 0.00 |
| So-Young (SY) | China | $0.116B | 39.00 |
| Oncology Institute (TOI) | United States | $0.087B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.048B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |